Loss of functional pancreatic islet β-cell mass leads to a deficiency in insulin secretion, leads to a deficiency in insulin secretion, the development of DM I and DM II, and metabolic disorders characterized by high blood glucose levels [148]. This evidence concerns the gene INS and metabolic disease.